Behind Eucalyptus' big bet that men will spend $1,000 a month on their health
With its biggest revenue driver in weight loss drugs like Ozempic facing uncertainty, Eucalyptus is expanding into men's longevity. But its offering isn’t cheap.
As a scythe hangs over their lucrative weight loss drug business, Eucalyptus co-founders Tim Doyle and Charlie Gearside are making their most ambitious bet yet – this time on the much-hyped longevity trend sweeping the health tech industry.
The bold venture, named Compound, promises to exhaustively assess a male user’s physical wellbeing and then optimise it step by step.
“[It’s] a medical concierge service, comprehensive diagnostics and structured program to improve every aspect of your health,” Gearside told Capital Brief.
The service comes with a premium price tag. Men can expect to pay $995 a month to participate in an initial 15-week ‘sprint’ program, replete with supplements, strength and conditioning programs, dieting and breathwork. Eligible customers can be prescribed Mounjaro, a branded weight loss drug, for an additional $500 a month. Women aren’t invited.
